Healthtech Growth Investors & VC Firms
1270 firms in this list, with a median first check of $1.6M. 311 of them lead rounds. Generated from verified public data and updated continuously.
Polaris Partners
BostonSeed–Growth$500K – $5M
45 people
NPM Capital N.V.
AmsterdamGrowth$32M – $320M
67 people
DG Daiwa Ventures
TokyoPre-Seed–Growth
32 people
Thompson Street Capital Partners
St. LouisGrowth–Late Stage$50M – $500M
62 people
Deutsche Beteiligungs AG
Frankfurt am MainGrowth–Late Stage
51 people
Altas Partners
TorontoGrowth–Late Stage
84 people
Dawson Partners
TorontoGrowth–Late Stage
85 people
Chiratae Ventures
BengaluruSeed–Growth$500K – $2M
44 people
Moscow Venture Fund (formerly Moscow Seed Fund)
MoscowPre-Seed–Late Stage
40 people
Mundi Ventures
MadridSeed–Growth$540K – $10.8M
29 people
Elsewhere Partners
AustinGrowth$20M – $50M
60 people
5AM Ventures
San FranciscoSeed–Late Stage$100K – $4M
41 people
Stifel Venture Banking
San FranciscoSeed–Late Stage
75 people
Source Code Capital
BeijingSeed–Growth
20 people
Kreos Capital
LondonSeries A–Late Stage
43 people
Bridges Fund Management Ltd.
LondonGrowth
71 people
NTT DOCOMO Ventures
TokyoSeed–Growth
2 people
Business Growth Fund
LondonSeed–Growth$3.8M – $38M
54 people
EQT Life Sciences
AmsterdamSeed–Late Stage$11M – $66M
59 people
Kaszek Ventures
MontevideoSeed–Late Stage
25 people
Spectrum Equity
BostonGrowth$25M – $250M
47 people
World Innovation Lab (WiL)
Palo AltoPre-Seed–Growth$5M – $30M
43 people
ICONIQ
San FranciscoSeries A–Growth
11 people
Oak Investment Partners
WiltonSeed–Late Stage
11 people
Related lists
Growth Investors & VC Firms (4264)Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)Growth Investors & VC Firms in North America (2122)Growth Investors & VC Firms in United States (1838)Growth Investors & VC Firms in Europe (1634)Healthtech Pre-Seed Investors & VC Firms (1468)
Data sourced from public filings and firms' own websites — see our methodology.


































































































